
Zim Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens
2026-03-23 14:37:37A sharp decline of 8.16% today dragged Zim Laboratories Ltd to a fresh 52-week low of Rs 63, extending its downward trajectory amid broader market weakness and company-specific concerns.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-03-23 10:10:16Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-03-22 10:10:13Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Aug 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd Stock Falls to 52-Week Low of Rs.63.48
2026-03-16 13:27:58Zim Laboratories Ltd has reached a new 52-week low of Rs.63.48 today, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance concerns.
Read full news article
Zim Laboratories Ltd Stock Hits 52-Week Low at Rs.64 Amidst Continued Downtrend
2026-03-13 10:05:26Zim Laboratories Ltd has touched a new 52-week low of Rs.64 today, marking a significant decline in its stock price amid a broader bearish trend in the Pharmaceuticals & Biotechnology sector. The stock has been under pressure for the past two days, falling by 4.42% during this period, and continues to trade below all key moving averages.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-03-10 10:10:18Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-02-27 10:10:17Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Zim Laboratories Ltd is Rated Strong Sell
2026-02-16 10:10:24Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news articleAre Zim Laboratories Ltd latest results good or bad?
2026-02-12 20:00:48Zim Laboratories Ltd's latest financial results for the third quarter of FY26 indicate a mixed performance characterized by some recovery in profitability and revenue growth, yet persistent operational challenges remain evident. The company reported a net profit of ₹4.40 crores, marking a turnaround from a loss in the previous quarter and a 10.00% increase year-on-year. Revenue also showed growth, rising to ₹108.66 crores, which reflects a 12.80% increase compared to the same quarter last year and a notable 22.49% increase from the previous quarter. Despite these positive indicators, the company's operating margin of 11.79% remains below the 12.00% achieved in the same quarter last year, highlighting ongoing cost pressures. The average return on equity (ROE) of 6.55% suggests challenges in capital efficiency, which is significantly lower than industry standards. Additionally, the company's nine-month perfo...
Read full news articleDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
18-Mar-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mathew Cyriac & PACs
Announcement Under Regulation 30- Constitution Of Advisory Board
17-Mar-2026 | Source : BSEPlease find enclosed the disclosure regarding constitution of advisory Board.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Mar-2026 | Source : BSEIntimation of schedule of Investor meet to be held on Friday 20th March 2026
Corporate Actions
No Upcoming Board Meetings
Zim Laboratories Ltd has declared 5% dividend, ex-date: 19 Sep 19
No Splits history available
Zim Laboratories Ltd has announced 2:1 bonus issue, ex-date: 22 Dec 22
No Rights history available






